Shots: The P-IIIB/IV study results involve assessing of Xeljanz XR (11 mg, qd) as monothx. followed by MTX withdrawal vs Xeljanz XR + MTX in 530 patients in ratio (1:1) […]readmore
Tags : Severe Rheumatoid Arthritis